Core Viewpoint - The establishment of the Lung Nodule Diagnosis and Treatment Center at Nanjing Mingji Hospital aims to provide comprehensive management for lung nodule patients, addressing the increasing detection rates and associated public anxiety while promoting early screening, diagnosis, and treatment of lung cancer [1][3]. Group 1: Center Objectives and Structure - The center integrates multidisciplinary resources to offer a full-cycle management approach, from precise screening to personalized follow-up and necessary interventions [1][3]. - It brings together experts from various fields, including thoracic surgery, respiratory and critical care medicine, imaging, pathology, and oncology, to collaboratively analyze and interpret lung nodules [3][4]. Group 2: Clinical Approach and Recommendations - The center emphasizes the importance of monitoring changes in lung nodules, particularly those under 8mm, suggesting that immediate intervention is not recommended unless significant changes occur [3]. - Early screening and detection are highlighted as the most effective means to combat lung cancer, with recommendations for high-risk individuals (aged 40+, long-term smokers, those with occupational exposure or family history) to include low-dose CT scans in their regular health check-ups [3][4]. Group 3: Patient Communication and Decision-Making - The center aims to create a "one-stop" management platform that not only focuses on technical assessments but also emphasizes effective communication and shared decision-making with patients [4]. - The goal is to ensure patients understand their nodule status, follow-up plans, and the rationale behind them, fostering a collaborative approach to healthcare [4].

Core Insights - Lung cancer is the most prevalent and deadly malignancy in China, with 1.0606 million new cases and 733,000 deaths reported in 2022 [1] - The five-year survival rate for lung cancer patients in China is gradually increasing, supported by national cancer prevention strategies [2] - Early diagnosis and treatment are crucial for improving survival rates, with multidisciplinary teams (MDT) playing a significant role in personalized treatment plans [3][4] Group 1: Lung Cancer Statistics and Trends - In 2022, China reported 1.0606 million new lung cancer cases and 733,000 deaths, highlighting the severity of the disease [1] - The "Healthy China 2030" initiative aims to increase the overall five-year cancer survival rate to 46.6% by 2030, with lung cancer survival rates also on the rise [2] Group 2: Early Detection and Management - The detection rate of lung nodules in China is approximately 20%, emphasizing the importance of public awareness regarding lung nodules as early signs of lung cancer [2] - Comprehensive management of lung nodules should include screening, follow-up, and intervention to enhance early detection and treatment [2] Group 3: Treatment Advances - Surgical intervention remains key for early-stage lung cancer, with minimally invasive techniques improving recovery times and treatment outcomes [3] - For late-stage lung cancer patients, treatment goals shift from cure to prolonging survival and enhancing quality of life, with new therapies like targeted and immunotherapy showing promise [3] Group 4: Multidisciplinary Approach - MDTs facilitate collaborative treatment planning by integrating expertise from various medical fields, leading to personalized and effective treatment strategies [4] - The MDT approach allows for a comprehensive evaluation of treatment options, optimizing decision-making and improving patient outcomes [4]